• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尽管接受了充分的药物治疗,肝性脑病仍与持续性学习障碍相关:一项多中心国际研究。

Hepatic Encephalopathy Is Associated with Persistent Learning Impairments Despite Adequate Medical Treatment: A Multicenter, International Study.

作者信息

Nardelli Silvia, Allampati Sanath, Riggio Oliviero, Mullen Kevin D, Prakash Ravi, Gioia Stefania, Unser Ariel, White Melanie B, Fagan Andrew C, Wade James B, Farcomeni Alessio, Gavis Edith A, Bajaj Jasmohan S

机构信息

Division of Gastroenterology, Sapienza University of Rome, Rome, Italy.

Division of Gastroenterology, Metrohealth Medical Center, Case Western Reserve University, Cleveland, OH, USA.

出版信息

Dig Dis Sci. 2017 Mar;62(3):794-800. doi: 10.1007/s10620-016-4425-6. Epub 2016 Dec 30.

DOI:10.1007/s10620-016-4425-6
PMID:28039670
Abstract

BACKGROUND

Hepatic encephalopathy (HE) is considered reversible regarding mental status but may not be cognitively in single-center studies.

AIM

To evaluate persistence of learning impairment in prior HE compared to those who never experienced HE (no-HE) in a multicenter study.

METHODS

A total of 174 outpatient cirrhotics from three centers (94 Virginia, 30 Ohio, and 50 Rome; 36 prior HE) underwent psychometric hepatic encephalopathy score (PHES) and inhibitory control (ICT) testing at baseline and then at least 7 days apart. ICT learning (change in 2nd half lures compared to 1st half) was compared between patient groups at both visits. Change in the PHES individual sub-tests and total score between visits was compared in both groups. US versus Italian trends were also analyzed.

RESULTS

HE patients had worse PHES and ICT results compared to no-HE patients at baseline. Significant improvement (1st half 7.1 vs. 2nd half 6.2, p < 0.0001) was observed in no-HE, but not in HE (1st half 7.9 vs. 2nd half 7.8, p = 0.1) at baseline. At retesting (median 20 days later), no-HE patients continued with significant learning (1st half 6.0 vs. 2nd half 5.4, p < 0.0001), while HE patients again did not improve (1st half 7.8 vs. 2nd half 6.9, p = 0.37). Between visits, no-HE patients improved significantly on four PHES sub-tests and overall score, while HE patients only improved on two sub-tests with similar overall PHES score. Trends were similar between US and Italian subjects.

CONCLUSION

In this multicenter study, prior HE patients showed persistent significant learning impairment compared to those without prior HE, despite adequate medical therapy. This persistent change should increase efforts to reduce the first HE episode.

摘要

背景

在单中心研究中,肝性脑病(HE)的精神状态被认为是可逆的,但认知功能可能并非如此。

目的

在一项多中心研究中,评估既往有HE的患者与从未经历过HE(无HE)的患者相比,学习障碍的持续性。

方法

来自三个中心的174名门诊肝硬化患者(94名来自弗吉尼亚州,30名来自俄亥俄州,50名来自罗马;36名既往有HE)在基线时接受了心理测量肝性脑病评分(PHES)和抑制控制(ICT)测试,然后至少间隔7天再次测试。在两次就诊时,比较了患者组之间的ICT学习情况(后半部分诱捕试验与前半部分相比的变化)。比较了两组就诊期间PHES各个子测试和总分的变化。还分析了美国和意大利患者的趋势。

结果

与无HE患者相比,HE患者在基线时的PHES和ICT结果更差。在无HE患者中观察到显著改善(前半部分7.1对后半部分6.2,p < 0.0001),但在HE患者中未观察到改善(前半部分7.9对后半部分7.8,p = 0.1)。在重新测试时(中位时间为20天后),无HE患者继续有显著学习进步(前半部分6.0对后半部分5.4,p < 0.

相似文献

1
Hepatic Encephalopathy Is Associated with Persistent Learning Impairments Despite Adequate Medical Treatment: A Multicenter, International Study.尽管接受了充分的药物治疗,肝性脑病仍与持续性学习障碍相关:一项多中心国际研究。
Dig Dis Sci. 2017 Mar;62(3):794-800. doi: 10.1007/s10620-016-4425-6. Epub 2016 Dec 30.
2
Persistence of cognitive impairment after resolution of overt hepatic encephalopathy.显性肝性脑病缓解后认知障碍的持续存在。
Am J Gastroenterol. 2014 Jul;109(7):1011-9. doi: 10.1038/ajg.2014.107. Epub 2014 Apr 29.
3
Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.肝硬化患者显性肝性脑病的一级预防:乳果糖与无乳果糖的开放性标签随机对照试验。
J Gastroenterol Hepatol. 2012 Aug;27(8):1329-35. doi: 10.1111/j.1440-1746.2012.07186.x.
4
Improving the inhibitory control task to detect minimal hepatic encephalopathy.改善抑制控制任务以检测轻微肝性脑病。
Gastroenterology. 2010 Aug;139(2):510-8, 518.e1-2. doi: 10.1053/j.gastro.2010.04.057. Epub 2010 May 11.
5
Review article: the modern management of hepatic encephalopathy.综述文章:肝性脑病的现代治疗管理。
Aliment Pharmacol Ther. 2010 Mar;31(5):537-47. doi: 10.1111/j.1365-2036.2009.04211.x. Epub 2009 Dec 7.
6
Value of critical flicker frequency and psychometric hepatic encephalopathy score in diagnosis of low-grade hepatic encephalopathy.临界闪烁频率和心理测肝性脑病评分在诊断轻度肝性脑病中的价值。
Gastroenterology. 2014 Apr;146(4):961-9. doi: 10.1053/j.gastro.2013.12.026. Epub 2013 Dec 21.
7
Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy.肝硬化和肝性脑病患者对乳果糖无应答的预测因素。
Eur J Gastroenterol Hepatol. 2010 May;22(5):526-31. doi: 10.1097/MEG.0b013e3283341b7d.
8
Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis.低钠血症和肝性脑病对肝硬化患者健康相关生活质量和脑代谢物异常的影响差异。
J Hepatol. 2013 Sep;59(3):467-73. doi: 10.1016/j.jhep.2013.04.023. Epub 2013 May 7.
9
Normalization of the psychometric hepatic encephalopathy score in Polish population. A prospective, quantified electroencephalography study.波兰人群中精神心理性肝性脑病评分的正常化。一项前瞻性、量化脑电图研究。
Liver Int. 2013 Oct;33(9):1332-40. doi: 10.1111/liv.12194. Epub 2013 May 8.
10
Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy.血清内毒素、炎症介质与轻微型肝性脑病患者治疗前后的磁共振波谱分析
J Gastroenterol Hepatol. 2013 Jul;28(7):1187-93. doi: 10.1111/jgh.12160.

引用本文的文献

1
A Comprehensive Overview of the Past, Current, and Future Randomized Controlled Trials in Hepatic Encephalopathy.肝性脑病过去、现在和未来的随机对照试验全面概述。
Medicina (Kaunas). 2023 Dec 10;59(12):2143. doi: 10.3390/medicina59122143.
2
Neurometabolic changes in a rat pup model of type C hepatic encephalopathy depend on age at liver disease onset.C 型肝性脑病幼鼠模型的神经代谢变化取决于肝病发病时的年龄。
Metab Brain Dis. 2023 Aug;38(6):1999-2012. doi: 10.1007/s11011-023-01210-w. Epub 2023 May 6.
3
Hepatic Encephalopathy: From Metabolic to Neurodegenerative.

本文引用的文献

1
Hepatic encephalopathy expands the predictivity of model for end-stage liver disease in liver transplant setting: Evidence by means of 2 independent cohorts.肝性脑病扩大了终末期肝病模型在肝移植环境中的预测能力:来自两个独立队列的证据。
Liver Transpl. 2016 Oct;22(10):1333-42. doi: 10.1002/lt.24517.
2
Absence of practice effects in preclinical Alzheimer's disease.临床前阿尔茨海默病中不存在练习效应。
Neuropsychology. 2015 Nov;29(6):940-8. doi: 10.1037/neu0000208. Epub 2015 May 25.
3
The etiology of cirrhosis is a strong determinant of brain reserve: A multimodal magnetic resonance imaging study.
肝性脑病:从代谢到神经退行性变。
Neurochem Res. 2021 Oct;46(10):2612-2625. doi: 10.1007/s11064-021-03372-4. Epub 2021 Jun 15.
4
Cognitive Impairment After Resolution of Hepatic Encephalopathy: A Systematic Review and Meta-Analysis.肝性脑病缓解后的认知障碍:一项系统评价和荟萃分析
Front Neurosci. 2021 Mar 10;15:579263. doi: 10.3389/fnins.2021.579263. eCollection 2021.
5
The Association between Hepatic Encephalopathy and Diabetic Encephalopathy: The Brain-Liver Axis.肝性脑病与糖尿病性脑病的关系:脑-肝轴。
Int J Mol Sci. 2021 Jan 5;22(1):463. doi: 10.3390/ijms22010463.
6
The Direct Contribution of Astrocytes and Microglia to the Pathogenesis of Hepatic Encephalopathy.星形胶质细胞和小胶质细胞对肝性脑病发病机制的直接贡献。
J Clin Transl Hepatol. 2019 Dec 28;7(4):352-361. doi: 10.14218/JCTH.2019.00025. Epub 2019 Nov 13.
7
Cognitive impairment after liver transplantation: residual hepatic encephalopathy or posttransplant encephalopathy?肝移植后的认知障碍:残留肝性脑病还是移植后脑病?
Hepat Med. 2019 Mar 18;11:41-46. doi: 10.2147/HMER.S144667. eCollection 2019.
8
Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo-Controlled Trial.粪便微生物胶囊在肝性脑病中是安全的:一项 1 期、随机、安慰剂对照试验。
Hepatology. 2019 Nov;70(5):1690-1703. doi: 10.1002/hep.30690. Epub 2019 Jun 18.
9
Understanding the impact of neurologic complications in patients with cirrhosis.了解肝硬化患者神经并发症的影响。
SAGE Open Med. 2019 Feb 28;7:2050312119832090. doi: 10.1177/2050312119832090. eCollection 2019.
10
Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of Rifaximin.系统评价肝性脑病显性经济负担及利福昔明的药物经济学影响
Pharmacoeconomics. 2018 Jul;36(7):809-822. doi: 10.1007/s40273-018-0641-6.
肝硬化的病因是脑储备的一个重要决定因素:一项多模态磁共振成像研究。
Liver Transpl. 2015 Sep;21(9):1123-32. doi: 10.1002/lt.24163. Epub 2015 Jul 21.
4
Ammonia-induced senescence in cultured rat astrocytes and in human cerebral cortex in hepatic encephalopathy.氨诱导培养的大鼠星形胶质细胞以及肝性脑病患者大脑皮质细胞衰老。
Glia. 2015 Jan;63(1):37-50. doi: 10.1002/glia.22731. Epub 2014 Aug 4.
5
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver.慢性肝病中的肝性脑病:美国肝病研究协会和欧洲肝脏研究协会2014年实践指南
Hepatology. 2014 Aug;60(2):715-35. doi: 10.1002/hep.27210. Epub 2014 Jul 8.
6
Persistence of cognitive impairment after resolution of overt hepatic encephalopathy.显性肝性脑病缓解后认知障碍的持续存在。
Am J Gastroenterol. 2014 Jul;109(7):1011-9. doi: 10.1038/ajg.2014.107. Epub 2014 Apr 29.
7
New-onset cognitive dysfunction impairs the quality of life in patients after liver transplantation.新发认知功能障碍会损害肝移植术后患者的生活质量。
Liver Transpl. 2014 Jul;20(7):807-14. doi: 10.1002/lt.23887. Epub 2014 May 26.
8
Diagnosis of covert hepatic encephalopathy without specialized tests.无需专门检测的隐匿性肝性脑病诊断
Clin Gastroenterol Hepatol. 2014 Aug;12(8):1384-1389.e2. doi: 10.1016/j.cgh.2013.12.020. Epub 2013 Dec 19.
9
Practice effects and longitudinal cognitive change in normal aging vs. incident mild cognitive impairment and dementia in the Mayo Clinic Study of Aging.在 Mayo 衰老研究中,正常衰老与轻度认知障碍和痴呆的发病相比,练习效应和纵向认知变化。
Clin Neuropsychol. 2013;27(8):1247-64. doi: 10.1080/13854046.2013.836567. Epub 2013 Sep 17.
10
Encephalopathy and liver transplantation.脑病与肝移植。
Metab Brain Dis. 2013 Jun;28(2):285-92. doi: 10.1007/s11011-012-9350-6. Epub 2012 Nov 16.